Table 1.
Clinical and demographic characteristics of the patients
| First group (n = 135) | Second group (n = 137) | p | |
|---|---|---|---|
| Age (year) | 65.27 ± 8.01 | 66.04 ± 7.55 | 0.4 |
| Total PSA (ng/ml) | 7.02 ± 1.94 | 6.38 ± 2.04 | 0.008 |
| Free PSA (ng/ml) | 0.72 ± 0.31 | 1.37 ± 0.61 | <0.001 |
| Free/Total PSA | 0.1 ± 0.03 | 0.21 ± 0.06 | <0.001 |
| Prostate volume (ml) | 38.13 ± 15.5 | 45.37 ± 20.01 | 0.003 |
| Gleason score | 6.60 ± 0.94 | 6.35 ± 0.8 | 0.037 |
First Group: free/total PSA ≤15%; Second Group: free/total PSA > 15%; PSA = prostate specific antigen